Faron Pharmaceuticals Oy Share Discussion Threads

[datait] 08/5/2018 09:48

longshanks4 Apr '17 - 12:27 - 14 of 133
0 0 0
I too am overwhelmed by the way this has risen in such a short space of time.

Truth is though that they have a great drug candidate to satisfy a large unmet need so should see rapid commercialisation assuming the Ph3 goes to plan.

I see no point in selling yet. Could easily see £10 this year.

[pwhite73] 08/5/2018 09:44

Oh really what do they know that no one else knows. Phase III has failed. The methodology used on all their other products is now under question.There is nothing here but day traders. Longs and shorts battling it out with only one winner the markets and one loser Joe Mug PI.

[ernestsyngen] 08/5/2018 09:34

Massive buying and the MM's are moving up

My guess is we have some big buyers

[inv] 08/5/2018 09:17

what a buying opportunity. Will easily go up to 250p plus today

[haroldthegreat] 08/5/2018 09:13

First time I heard him present I found it difficult to follow because of his accent. I recently heard him present again and still found difficulty in following the presentation but was impressed by the chart and his optimism for the trial results when they come out. Luckily I did not purchase.
The CEO of falcon once said he would summarise his disclaimer as don't believe a word i say. I was so impressed I purchased his shares !
They did go down ,as all oil shares did,but I liked his principle of farming out so the drilling had little risk to falcon,but retaining a stake so if there was a success he shared in the upside.
Recent events in Australia have rewarded shareholds.

[pwhite73] 08/5/2018 08:57

Err no. The company is finished. The price today will end so that 90% of buyers are nursing losses.

[ernestsyngen] 08/5/2018 08:50

Fill your boots for an easy recovery play here!

[ernestsyngen] 08/5/2018 08:48

Massive profit to be made form this drop easy !

Fill your boots for 200 + at end of day

[diku] 08/5/2018 08:15

Banana skin?..


Morale of story is those who bought around 300p & see it go to 800p...take the money don't hang around on hope of going to the moon...

[11_percent] 08/5/2018 08:15

AND the smart money knew last week.
============

Indeed Toffeeman.
Not smart, just had the results.

[spawny100] 08/5/2018 08:06

Jeez commiserations for any holders. IMM mk2 it seems

[toffeeman] 08/5/2018 08:06

Thank goodness I only had a very small nibble!

AND the smart money knew last week.

[11_percent] 08/5/2018 08:00

open set = £2

[moneytree1] 08/5/2018 07:58

anyone paying £8 after the rise it had would have to have been a complete nutjob anyway,as would anyone who hadn't cashed in on the rise.

[11_percent] 08/5/2018 07:40

How far south will this one open !?

Don't know, but this is a one trick pony.......£1 seems a bit extreme, will go for £2.50.

[mad foetus] 08/5/2018 07:32

Really surprising after they had gone so far with arranging large scale manufacturing etc. It goes to show the risks involved in any drug development company. Very sad as well as there is a big unmet need here. As for the SP, I don't know enough about FARN to judge whether it will be a buy, but I would imagine it will be market down to under £1.

[twistednik] 08/5/2018 07:29

Wow - surprising results. How far south will this one open !?

[11_percent] 08/5/2018 07:11

This is not going to be good.

Now we know why the share price was going down and the insiders were selling.

[douglas fir] 08/5/2018 07:08

Faron announces top line data from the Phase III INTEREST trial with Traumakine in the treatment of ARDS



· INTEREST study did not meet the primary composite end point for efficacy

· Both Traumakine and placebo reported similar all cause mortality rates at day 28 and at day 90, with no difference in the number of ventilator free days

· Further investigations are currently underway to provide additional information on the outcome of the current analysis

[allonblack] 07/5/2018 14:17

Just a heads up. Faron have posted a job advert for a US Commercial Director today. Odd move a day ahead of results? I guess they are still confident in selling Traumakine into the US.

[chrysalis99] 05/5/2018 12:36

The chart is irrelevant. It's the trial results that count. Those that have researched have already taken their positions.

[immy1992] 05/5/2018 11:23

I think it's important to mention here that for every seller there is a buyer. If you look at the whole years chart there's always been monthly 10 percent fluctuations.

Some Could be overexposed and derisking. In hindsight it's only dropped 10 percent this week. I remain optimistic until a certain price point, I'll wait to see what happens on Monday before making a call.

I'm just speculating here 11%. From phase2b it says the results are 1 percent due to chance. With 30 percent wiggle room for primary endpoint.


Don't forget that the interest trials endpoint is for direct approval in Europe. If they show+50 percent off the bat they will get approved. If they show maybe 40 percent or so, they'll have to wait for the Japanese trial to confirm whatever efficacy they show in this trial to get approval in eu , subsequently the us

What I like here is that the company has a very detailed action plan and contingency plan in place in the event the interest trial does not hit their primary in this trial

[opodio] 05/5/2018 02:22

chart nasty

[11_percent] 04/5/2018 10:17

At best it Creates an opportunity for Mms to shake and steal shares.

==========

immy1992,

This is not a "tree shake".......has gone on too long.